{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:18:50Z","timestamp":1792030730899,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The profile of patients with pulmonary arterial hypertension (PAH) and positive acute haemodynamic response (acute responders) who may benefit on long-term calcium channel blocker (CCB) therapy is not yet well documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The aim of this study was to identify the subgroup of patients with PAH from the Polish Multicenter Registry of Pulmonary Hypertension (BNP-PL) who were found to be responders at the initial acute pulmonary vasoreactivity test (APV-test), and analyse the frequency, characteristics and prognosis of patients with different long-term response to treatment with CCB. Out of 534 patients 49 (9.2%) fulfilled the responder criteria (acute responders). Patients with positive APV test had a less advanced WHO class (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), longer distance in a 6-minute walking test (6MWT) and had a significantly lower NTproBNP compared to non-acute responders (540\u00a0m\/IQR:480\u2013560\/ vs. 280\u00a0m\/IQR:160\u2013390\/,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; 503.2 pg\/ml\/IQR:214.6\u20131533\/ vs. 2019 pg\/ml\/IQR:806\u20134286\/,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; respectively). The hemodynamic profile of the above two groups (acute responders and non-acute responders) was similar. CCB long-term response was found in 55.1% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927) of acute responders. All-cause mortality was lower among acute responders (11.54%) compared to non-acute responders (36.07%);\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039. Among acute responders, long-term responders showed markedly lower mortality (0%) compared to non-long-term responders (21.05%);\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Novel analysis in a unique large Polish PAH population highlights that APV testing and rapid early post-CCB assessment are key to long-term prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04250-4","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:28:17Z","timestamp":1771997297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prevalence and long-term response to calcium channel blockers in patients with pulmonary arterial hypertension and positive vasoreactivity test \u2013 results of multicenter national registry (BNP-PL)"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9326-0711","authenticated-orcid":false,"given":"Micha\u0142","family":"Pi\u0142ka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Darocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Walig\u00f3ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Kope\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Florczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Mularek-Kubzdela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Smukowska-Gorynia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Lewicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Mroczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Chrzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"B\u0142aszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Ku\u015bmierczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ptaszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mizia-Stec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Peregud-Pogorzelska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Jache\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Skoczylas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Jaguszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Grze\u015bk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Betkier-Lipi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Pruszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Widejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judyta","family":"Winowska-J\u00f3zwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kurzyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"4250_CR1","doi-asserted-by":"crossref","unstructured":"Humbert M, Guignabert C, Bonnet S, Dorfmuller P, Klinger JR, Nicolls MR, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1).","DOI":"10.1183\/13993003.01887-2018"},{"issue":"38","key":"4250_CR2","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"4","key":"4250_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.rmed.2009.11.015","volume":"104","author":"AR Tonelli","year":"2010","unstructured":"Tonelli AR, Alnuaimat H, Mubarak K. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med. 2010;104(4):481\u201396.","journal-title":"Respir Med"},{"key":"4250_CR4","doi-asserted-by":"crossref","unstructured":"Galie N, Channick RN, Frantz RP, Grunig E, Jing ZC, Moiseeva O, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53(1).","DOI":"10.1183\/13993003.01889-2018"},{"issue":"23","key":"4250_CR5","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","volume":"111","author":"O Sitbon","year":"2005","unstructured":"Sitbon O, Humbert M, Jais X, Ioos V, Hamid AM, Provencher S, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111(23):3105\u201311.","journal-title":"Circulation"},{"issue":"6","key":"4250_CR6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1161\/01.CIR.71.6.1191","volume":"71","author":"S Rich","year":"1985","unstructured":"Rich S, Brundage BH, Levy PS. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation. 1985;71(6):1191\u20136.","journal-title":"Circulation"},{"issue":"2","key":"4250_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1056\/NEJM199207093270203","volume":"327","author":"S Rich","year":"1992","unstructured":"Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327(2):76\u201381.","journal-title":"N Engl J Med"},{"issue":"20","key":"4250_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.122.063821","volume":"149","author":"F Gerhardt","year":"2024","unstructured":"Gerhardt F, Fiessler E, Olsson KM, Kayser MZ, Kovacs G, Gall H, et al. Positive vasoreactivity testing in pulmonary arterial hypertension: therapeutic Consequences, treatment Patterns, and outcomes in the modern management era. Circulation. 2024;149(20):1549\u20136421.","journal-title":"Circulation"},{"issue":"10","key":"4250_CR9","doi-asserted-by":"publisher","first-page":"972","DOI":"10.33963\/KP.14988","volume":"77","author":"G Kopec","year":"2019","unstructured":"Kopec G, Kurzyna M, Mroczek E, Chrzanowski L, Mularek-Kubzdela T, Skoczylas I, et al. Database of pulmonary hypertension in the Polish population (BNP-PL): design of the registry. Kardiol Pol. 2019;77(10):972\u20134.","journal-title":"Kardiol Pol"},{"key":"4250_CR10","doi-asserted-by":"crossref","unstructured":"Kopec G, Kurzyna M, Mroczek E, Chrzanowski L, Mularek-Kubzdela T, Skoczylas I, et al. Characterization of patients with pulmonary arterial hypertension: data from the polish registry of pulmonary hypertension (BNP-PL). J Clin Med. 2020;9(1).","DOI":"10.3390\/jcm9010173"},{"issue":"1","key":"4250_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5603\/KP.2015.0011","volume":"73","author":"M Kurzyna","year":"2015","unstructured":"Kurzyna M, Araszkiewicz A, Blaszczak P, Grabka M, Hawranek M, Kopec G, et al. Summary of recommendations for the haemodynamic and angiographic assessment of the pulmonary circulation. Joint statement of the Polish cardiac society\u2019s working group on pulmonary circulation and association of cardiovascular interventions. Kardiol Pol. 2015;73(1):63\u20138.","journal-title":"Kardiol Pol"},{"issue":"12","key":"4250_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5603\/KP.2015.0242","volume":"73","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. [2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension]. Kardiol Pol. 2015;73(12):1127\u2013206.","journal-title":"Kardiol Pol"},{"issue":"7","key":"4250_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of Cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr. 2010;23(7):685\u2013713. quiz 86\u2009\u2013\u20098.","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"4250_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.5603\/KP.2016.0070","volume":"74","author":"R Baranowski","year":"2016","unstructured":"Baranowski R, Wojciechowski D, Kozlowski D, Kukla P, Kurpesa M, Lelakowski J, et al. [Compendium for performing and describing the resting electrocardiogram. Diagnostic criteria describe rhythm, electrical axis of the heart, QRS voltage, automaticity and conduction disorders. Experts\u2019 group statement of the working group on noninvasive Ele]. Kardiol Pol. 2016;74(5):493\u2013500.","journal-title":"Kardiol Pol"},{"issue":"1","key":"4250_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"4250_CR16","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","volume":"31","author":"D Montani","year":"2010","unstructured":"Montani D, Savale L, Natali D, Jais X, Herve P, Garcia G, et al. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. Eur Heart J. 2010;31(15):1898\u2013907.","journal-title":"Eur Heart J"},{"key":"4250_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1055\/s-2007-1006395","volume":"15","author":"MM Hoeper","year":"1994","unstructured":"Hoeper MM, Wilke T, Welte T, Breuer H-WM, Wagner TOF. How effective is the treatment with high-dose Nifedipine for primary pulmonary hypertension? Semin Respir Crit Care Med. 1994;15:490\u20134.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"4250_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/01.CIR.93.3.484","volume":"93","author":"O Raffy","year":"1996","unstructured":"Raffy O, Azarian R, Brenot F, Parent F, Sitbon O, Petitpretz P, et al. Clinical significance of the pulmonary vasodilator response during short-term infusion of Prostacyclin in primary pulmonary hypertension. Circulation. 1996;93(3):484\u20138.","journal-title":"Circulation"},{"issue":"2 Pt 1","key":"4250_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1164\/ajrccm.151.2.7842196","volume":"151","author":"O Sitbon","year":"1995","unstructured":"Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with Prostacyclin. Am J Respir Crit Care Med. 1995;151(2 Pt 1):384\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"4250_CR20","unstructured":"Simonneau G, Herv\u00e9 P, Petitpretz P, Girard P, Salmeron S, Escourrou P, et al. Detection of a reversible component in primary pulmonary hypertension: value of prostacyclin acute infusion. Am Rev Respir Dis. 1986;133:A223. Abstract."},{"issue":"6","key":"4250_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1183\/09031936.00169608","volume":"33","author":"ZC Jing","year":"2009","unstructured":"Jing ZC, Jiang X, Han ZY, Xu XQ, Wang Y, Wu Y, et al. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension. Eur Respir J. 2009;33(6):1354\u201360.","journal-title":"Eur Respir J"},{"issue":"1","key":"4250_CR22","first-page":"62","volume":"18","author":"A Kiani","year":"2023","unstructured":"Kiani A, Omidvar R, Naderi N, Taghavi S, Mirtajaddini M. The Long-Term response to treatment with calcium channel blockers in patients with idiopathic pulmonary arterial hypertension. J Tehran Heart Cent. 2023;18(1):62\u20137.","journal-title":"J Tehran Heart Cent"},{"key":"4250_CR23","doi-asserted-by":"crossref","unstructured":"Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Grunig E, et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2022;60(1).","DOI":"10.1183\/13993003.02311-2021"},{"key":"4250_CR24","doi-asserted-by":"crossref","unstructured":"Boucly A, Weatherald J, Savale L, de Groote P, Cottin V, Prevot G, et al. External validation of a refined four-stratum risk assessment score from the french pulmonary hypertension registry. Eur Respir J. 2022;59(6).","DOI":"10.1183\/13993003.02419-2021"},{"key":"4250_CR25","doi-asserted-by":"crossref","unstructured":"Boucly A, Weatherald J, Savale L, Jais X, Cottin V, Prevot G, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017;50(2).","DOI":"10.1183\/13993003.00889-2017"},{"issue":"1","key":"4250_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jjcc.2023.01.005","volume":"82","author":"S Ishii","year":"2023","unstructured":"Ishii S, Hatano M, Maki H, Minatsuki S, Saito A, Yagi H, et al. Prognostic value of follow-up vasoreactivity test in pulmonary arterial hypertension. J Cardiol. 2023;82(1):69\u201375.","journal-title":"J Cardiol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04250-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04250-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04250-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:53:15Z","timestamp":1774972395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04250-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4250"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04250-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}